nAture medicine Foxp3-expressing T reg cells have an essential role in suppressing immune responses [1] [2] [3] [4] [5] . Mice deficient in Foxp3 develop fatal autoimmune disease 3, 4 , and continuous expression of Foxp3 throughout life prevents autoimmunity 6 . Thus, the stability of Foxp3 expression influences the balance between tolerance and autoimmunity, as well as the efficacy of T reg cell-based therapies. The instability of Foxp3 may underlie the pathogenesis of autoimmune diabetes and lethal protozoa infection 7-9 , but this concept has been challenged by a report showing that Foxp3 expression is stable in in vivo disease models, including autoimmune arthritis 10 . A debate has arisen as to whether the plasticity of Foxp3-expressing T reg cells is pathologically relevant. T reg cell development and function are regulated by IL-2, which binds to the receptor complex containing IL-2Rα (also called CD25). It was recently shown that Foxp3 + cells are comprised of Foxp3-stable CD25 hi and Foxp3-unstable CD25 lo populations 11, 12 , the former of which is composed of bona fide T reg cells with sustained Foxp3 expression 11 . However, the pathological importance of the latter Foxp3-unstable CD25 lo population remains unclear.
Foxp3-expressing T reg cells have an essential role in suppressing immune responses [1] [2] [3] [4] [5] . Mice deficient in Foxp3 develop fatal autoimmune disease 3, 4 , and continuous expression of Foxp3 throughout life prevents autoimmunity 6 . Thus, the stability of Foxp3 expression influences the balance between tolerance and autoimmunity, as well as the efficacy of T reg cell-based therapies. The instability of Foxp3 may underlie the pathogenesis of autoimmune diabetes and lethal protozoa infection [7] [8] [9] , but this concept has been challenged by a report showing that Foxp3 expression is stable in in vivo disease models, including autoimmune arthritis 10 . A debate has arisen as to whether the plasticity of Foxp3-expressing T reg cells is pathologically relevant. T reg cell development and function are regulated by IL-2, which binds to the receptor complex containing IL-2Rα (also called CD25). It was recently shown that Foxp3 + cells are comprised of Foxp3-stable CD25 hi and Foxp3-unstable CD25 lo populations 11, 12 , the former of which is composed of bona fide T reg cells with sustained Foxp3 expression 11 . However, the pathological importance of the latter Foxp3-unstable CD25 lo population remains unclear.
RESULTS

T H 17 cells arise from CD25 lo Foxp3 + T cells in arthritis
To evaluate the in vivo stability of Foxp3 in Foxp3 + CD4 + T cells and its impact on collagen-induced arthritis (CIA), we adoptively transferred CD25 hi Foxp3 + CD4 + or CD25 lo Foxp3 + CD4 + T cells into mice that we immunized with type II collagen 3 weeks before. One day after transfer, we subjected the mice to secondary immunization with collagen. We efficiently obtained Foxp3 + cells by sorting hCD2 + cells from Foxp3 hCD2 knock-in mice 11 . hCD2-mediated enrichment of Foxp3 + cells enabled us to isolate CD25 lo Foxp3 + cells with high purity (Supplementary Fig. 1 ). We found that the transfer of CD25 hi Foxp3 + CD4 + , but not CD25 lo Foxp3 + CD4 + , T cells reduced joint swelling (Fig. 1a) and bone destruction (Fig. 1b) without affecting the production of collagen-specific antibodies ( Supplementary Fig. 2 ). To examine the stability of Foxp3, we labeled donor CD25 hi Foxp3 + CD4 + or CD25 lo Foxp3 + CD4 + T cells with carboxyfluorescein succinimidyl ester (CFSE) and monitored Foxp3 expression in donor-derived (CFSE + ) CD4 + T cells 1 week after secondary immunization. The majority of CD25 hi Foxp3 + CD4 + T cells (>95%) retained Foxp3 expression, but CD25 lo Foxp3 + CD4 + T cells lost Foxp3 expression in the spleen (35%) and draining lymph nodes (dLNs) (75%) under arthritic conditions (Fig. 1c) . These results suggest that the transferred CD25 lo Foxp3 + CD4 + T cells failed to inhibit inflammation and bone destruction because of their loss of Foxp3.
To follow the transferred cells for a longer period of time, we used donor T cells from B6 Ly5.1 + Foxp3 hCD2 congenic mice and analyzed Foxp3 and IL-17 expression 2 weeks after secondary immunization in donor-derived Ly5.1 + CD4 + T cells in host mice with arthritis. The majority of transferred total Foxp3 + or CD25 hi Foxp3 + T cells retained Foxp3 expression, which is consistent with a previous report 10 . In contrast, when we purified and transferred CD25 lo Foxp3 + CD4 + T cells to the arthritic mice, these cells lost Foxp3 expression (30-50%) (Fig. 1d) , and the percentage of IL-17-expressing cells in the donorderived Foxp3 − CD4 + T cells (10-25%) was much greater than that in host-derived Foxp3 − CD4 + T cells (<3%) (Fig. 1e and Supplementary  Fig. 3 ). Thus CD25 lo Foxp3 + CD4 + T cells preferentially lose Foxp3 and produce IL-17 in arthritic mice after adoptive transfer.
To determine the contribution of naive CD4 + and CD25 lo Foxp3 + CD4 + T cells to T H 17 cell development under arthritic . All data are shown as the mean ± s.e.m. Statistical analyses were performed using unpaired two-tailed Student's t test (*P < 0.05, **P < 0.01, ***P < 0.005; NS, not significant (refs. 13,14) to a much greater extent than did naive CD4 + donor-derived or hostderived Foxp3 − CD4 + T cells (Fig. 1f) . These findings suggest that under arthritic conditions, CD25 lo Foxp3 + CD4 + T cells are prone to differentiate into T H 17 cells that are known to have a key pathological role in arthritis [13] [14] [15] [16] [17] [18] .
Characterization of exFoxp3 T cells in arthritic mice
To monitor the localization of exFoxp3 T cells in vivo, we crossed Foxp3 bacterial artificial chromosome transgenic mice expressing the GFP-Cre recombinase fusion protein 7 with ROSA26-YFP reporter mice 19 . GFP indicates cells that are currently expressing Foxp3, whereas YFP marks cells that are expressing or did express Foxp3. Under arthritic conditions, the percentage of exFoxp3 (GFP − YFP + ) cells (as a proportion of total CD4 + T cells) was higher in joints than in other lymphoid organs ( Fig. 2a and Supplementary Fig. 4) , suggesting a preferential accumulation of exFoxp3 T cells in the synovium. In addition, exFoxp3 (GFP − YFP + ) T cells expressed higher levels of CCR6 and RANKL than did GFP − YFP − T cells in popliteal LNs (Fig. 2b) . Notably, the percentage of IL-17 + cells among exFoxp3 T cells was highest in arthritic joints (Fig. 2c) 20, 22 . Flow cytometric analysis indicated that GITR (also called TNFRSF18), neuropilin 1 (Nrp1) and killer cell lectin-like receptor subfamily G member 1 (KLRG1) were similarly expressed by exFoxp3 T cells and GFP + YFP + T cells (Fig. 2d) . exFoxp3 T cells also expressed CD25, folate receptor 4 (FR4), OX40 (also called TNFRSF4), CD39 (also called ENTPD1), CD103 (also called ITGAE) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4), albeit to a lesser extent compared to GFP + YFP + T cells ( Fig. 2d and Supplementary Fig. 5 ). Thus, although the expression level of a few T reg marker genes, including CD25 and FR4, was lower in exFoxp3 T cells than in GFP + YFP + T cells, exFoxp3 T cells expressed most of the phenotypic T reg markers and were distinguishable from activated conventional T cells that transiently express Foxp3 (Fig. 2d) .
Methylation analysis of the Foxp3, Il2ra and Ctla4 loci 22 in exFoxp3 T cells isolated from spleens and dLNs of arthritic mice revealed that the Foxp3 locus was largely methylated and the Il2ra locus was partially methylated in exFoxp3 (GFP − YFP + ) T cells (Fig. 2e) . As the Foxp3 locus in tT reg cells is known to be demethylated 22 , the data suggest that exFoxp3 T cells are not derived from tT reg cells. The Ctla4 locus of exFoxp3 T cells was demethylated, making these cells distinct from effector memory T cells and in vitro-induced T reg cells 22 .
Genome-wide expression analysis showed that exFoxp3 T H 17 cells highly express Cxcr5, Ccr8, Rora and Rorc, which are preferentially expressed in pT reg cells that are generated through antigen delivery or in T reg cells in the gut lamina propria 23 ( Supplementary Fig. 6 ), but have lower expression of Ikzf2 (Fig. 3a) . These exFoxp3 T cells upregulate IL-17 but do not express interferon-γ (IFN-γ) or IL-4 when cocultured with arthritic synovial fibroblasts (Fig. 3a,b) , suggesting that arthritic synovial fibroblasts promote the conversion of Foxp3 + T cells to T H 17 cells in the joints. In contrast, when we cocultured naive CD4 + T cells with Thy1 + CD11b − synovial fibroblasts, they did not differentiate into T H 17 cells (Fig. 3b) . We detected IL-17 + Foxp3 + T cells, which may appear at the transition stage during the conversion of Foxp3 + T cells to T H 17 cells, in the joints and lymph nodes of arthritic mice (Supplementary Fig. 7) , as well as in the synovium of human subjects with RA (Supplementary Fig. 8 ).
We next investigated the mechanism by which synovial fibroblasts induce the conversion of Foxp3 + CD4 + T cells into T H 17 cells. The culture supernatant of synovial fibroblasts (Fig. 3c) or coculture of Foxp3 + CD4 + T cells with transwell-separated synovial fibroblasts (Fig. 3d) induced conversion into T H 17 cells, indicating that cell-cell contact is not essential for conversion. We explored the soluble factors mediating this conversion by analyzing the expression of various cytokines in the supernatant (Fig. 3e and data not shown) and found that IL-6 was highly produced by Thy1 + CD11b − cells (Fig. 3e) . The expression of IL-6 by arthritic synovial fibroblasts was further enhanced by IL-17, suggesting a potential positive feedback loop (Fig. 3e) . A neutralizing antibody against IL-6, but neither an antibody to TNF-α nor one to IL-1β, inhibited the generation of T H 17 cells after the coculture of Foxp3 + CD4 + T cells with synovial fibroblasts (Fig. 3f) . These results indicate that synovial fibroblast-derived IL-6 has a crucial role in the conversion of Foxp3 + CD4 + T cells to T H 17 cells.
exFoxp3 T H 17 cells are potent osteoclastogenic T cells
To evaluate the contribution of T H 17 cells of a Foxp3 + T cell origin to the bone destruction that occurs in arthritis, we examined their ability to induce osteoclatogenesis by counting the number of osteoclasts defined by TRAP + multinucleated cells (MNCs) and the expression of RANKL, a cytokine that is essential for osteoclast differentiation 16 , in comparison with both naive CD4 + T cell-derived T H 17 cells and Foxp3 + T cells. We found that exFoxp3 T H 17 cells had higher osteoclastogenic ability than naive CD4 + T cell-derived T H 17 cells in a coculture of synovial fibroblasts and bone marrow-derived monocyte and macrophage precursor cells (BMMs) (Fig. 4a,b) . Foxp3 + T cells cultured in the presence of IL-2 did not have osteoclastogenic ability, which is consistent with a previous report 24 . We confirmed these findings further using Foxp3 hCD2 mice crossed with IL-17-GFP knock-in mice, which enabled us to purify IL-17-expressing cells (Supplementary Fig. 9 ). npg The osteoclastogenic ability of T H 17 cells has been attributed mainly to their production of IL-17, which stimulates RANKL expression in fibroblasts, as T H 17 cells alone cannot induce osteoclastogenesis despite their RANKL expression 25 . However, Il17a −/− exFoxp3 T cells that were differentiated under T H 17-polarizing conditions still induced osteoclastogenesis, suggesting a potential contribution of T cell-derived RANKL or RANKL-inducing cytokines other than IL-17A (Fig. 4b) . We observed that exFoxp3 T H 17 cells expressed higher amounts of RANKL than did naive CD4 + T cell-derived T H 17 cells (Fig. 4c) . All data are representative of three independent experiments with triplicate culture wells and are shown as the mean ± s.e.m. Statistical analyses were performed using unpaired two-tailed Student's t test (*P < 0.05, ***P < 0.005).
npg the expression of RANKL in exFoxp3 T H 17 cells (Fig. 4c) . Notably, exFoxp3 T H 17 cells alone induced osteoclastogenesis from BMMs, even in the absence of synovial fibroblasts (Fig. 4d) . To elucidate the relative contribution of RANKL in exFoxp3 T H 17 cells and synovial fibroblasts, we used exFoxp3 T H 17 cells from Lck-Cre Tnfsf11 (encoding RANKL) flox/∆ Foxp3 hCD2 mice or Tnfsf11-deficient synovial fibroblasts in the T cell and synovial fibroblast coculture system. Although RANKL expressed on synovial fibroblasts has a major role in promoting osteoclastogenesis, RANKL expressed by exFoxp3 T H 17 cells was able to induce osteoclastogenesis, even in the absence of RANKL expression on synovial fibroblasts (Fig. 4e,f) . To gain molecular insight into the pathogenicity of exFoxp3 T H 17 cells, we performed GeneChip analysis of exFoxp3 T H 17 cells and naive CD4 + -derived T H 17 cells. exFoxp3 T H 17 cells expressed higher amounts of Ccr6, Ccl20, Il23r, Il17re, Tnfrsf21, Vcam1, Rorc and Tnfsf11 but lower amounts of Csf2, Tnf, Il10 and Sgk1 than T H 17 cells (Fig. 4g,h and Supplementary Fig. 10 ). These data suggest that exFoxp3 T H 17 cells are not identical to any known pathogenic T H 17 cell subsets [26] [27] [28] [29] . Notably, we found that exFoxp3 T H 17 cells specifically and highly express the transcription factor Sox4, which positively regulates RORγt (encoded by Rorc) 30 and enhances lymphoid cell survival 31 . The high expression of molecules that are involved in proliferation, such as Pik3r3, and the high frequency of Ki-67 + cells in exFoxp3 T cells (Supplementary Figs. 10 and 11) suggest that under arthritic conditions, exFoxp3 T H 17 cells are proliferative. Thus, exFoxp3 T H 17 cells comprise a new pathogenic T H 17 cell subset that expresses Sox4, CCR6, CCL20, IL-23R, IL-17RE and RANKL.
Autoreactive CD25 lo Foxp3 + T cells promote arthritis Self tolerance is maintained by thymic-derived stable Foxp3 + CD4 + T cells, which have a higher affinity for self antigens 32, 33 . We hypothesized that unstable Foxp3 + CD4 + T cells also contain self-reactive T cells and thus exert a potent arthritogenic effect after losing Foxp3 expression. To investigate the role of autoantigen-specific exFoxp3 T cells, we purified CD25 lo Foxp3 + , CD25 hi Foxp3 + , total Foxp3 − and effector memory CD44 hi Foxp3 − CD4 + T cells from collagen-immunized DBA/1 Foxp3 hCD2 mice, which harbor collagen-specific T cells. After CFSE labeling, we transferred these cells into immunized mice 1 d before secondary immunization. Notably, CD25 lo Foxp3 + T cells accelerated the onset and increased the severity of arthritic symptoms more than total Foxp3 − or CD44 hi Foxp3 − CD4 + T cells (Fig. 5a-c) . In contrast, the transfer of CD25 hi Foxp3 + CD4 + T cells markedly inhibited osteoclast formation. More than half (50-70%) of the CD25 lo Foxp3 + T cells lost Foxp3 expression, whereas almost all (>96%) of the CD25 hi Foxp3 + cells retained Foxp3 expression (Fig. 5d) . CD25 lo Foxp3 + cells proliferated in response to type II collagen in vitro to a greater extent than did CD25 hi Foxp3 + cells, suggesting that the CD25 lo Foxp3 + cells contained a higher number of autoreactive T cells (Fig. 5e) .
To further examine whether the exacerbation of arthritic symptoms elicited by CD25 lo Foxp3 + CD4 + T cells is dependent on type II collagen-specific responses, we transferred CD25 lo Foxp3 + CD4 + T cells from ovalbumin (OVA)-immunized mice to collagen-immunized mice. OVA-specific CD25 lo Foxp3 + CD4 + T cells did not exacerbate arthritis scores (Fig. 5a) . These results suggest that autoreactive pathogenic CD4 + T cells were generated mainly from CD25 lo Foxp3 + CD4 + T cells under arthritic conditions.
DISCUSSION
This study demonstrates that CD4 + T H 17 cells with arthritogenic and autoreactive properties arise from Foxp3 + CD4 + T cells, thus establishing the in vivo pathological importance of Foxp3 + CD4 + T cell conversion to T H 17 cells. The pathogenic function of IL-17 + exFoxp3 T cells may be enhanced by their higher affinity to self antigens, as well as their ability to accumulate and proliferate in inflamed tissues and stimulate 34 , but the fate of plastic Foxp3 + T cells may also be determined by this cytokine balance 35 (Supplementary Fig. 12) . Blockade of IL-6 sig naling increases the ratio of Foxp3 + to T H 17 cells in the course of RA treatment 36 , suggesting that some of the beneficial effects of these therapies may derive from regulation of the plasticity of Foxp3 + T cell fate. Blockade of TNF-α also increases the ratio of T reg to T H 17 cells 37, 38 , and it was recently reported that this effect is attributable to the recovery of T reg cell function 38 . These reports suggest that regulating the balance of T reg to T H 17 cells is important for the treatment of RA. Several RAassociated genes 39 , including Ptpn22, Ccr6 and Tnfrsf14, are highly expressed in exFoxp3 T H 17 cells (Supplementary Fig. 13) , and we observed IL-17 + Foxp3 + T cells in subjects with active RA (Supplementary Fig. 8 ), suggesting the potential role of exFoxp3 T H 17 cells in the pathogenesis of RA. Notably, we found that exFoxp3 T H 17 cells specifically express a set of surface molecules that may be useful in identifying arthritogenic T cells and may contribute to future diagnostic and therapeutic strategies for RA (Supplementary Fig. 10d ). The presence of exFoxp3 T H 17 cells may be used as a biomarker for RA and be useful for predicting responsiveness to anti-IL-6 therapy. Further characterization of the mechanisms underlying the conversion and function of plastic Foxp3 + T cells will provide new insights into the maintenance and restoration of self tolerance, and this will in turn lead to the development of new therapeutic strategies for autoimmune diseases.
METHODS
Methods and any associated references are available in the online version of the paper. 
